The Readout LOUD Damian Garde, Meg Tirrell and Adam Feuerstein Listen: Mysterious infections, dwindling Covid funds, & Shkreli out of prison
The Readout LOUD Damian Garde, Meg Tirrell and Adam Feuerstein Listen: A CEO’s arrest, Pfizer’s big deal, & Covid on the rise
The Readout LOUD Damian Garde, Meg Tirrell and Adam Feuerstein Listen: Succession at Biogen, surprises at Vertex, & a potential superspreader dinner
The Readout LOUD Damian Garde, Meg Tirrell and Adam Feuerstein Listen: How cancer-killing cell therapies work, biotech’s endless downturn, & an FDA conundrum
The Readout LOUD Damian Garde, Meg Tirrell and Adam Feuerstein Listen: An ominous biotech deal, vaccines for kids, & ‘breakthrough’ devices
The Readout LOUD Damian Garde, Meg Tirrell and Adam Feuerstein Leana Wen talks Covid risk tolerance and her response to critics
The Readout LOUD Damian Garde, Meg Tirrell and Adam Feuerstein Listen: Leana Wen on the pandemic’s new normal and whether Twitter is real life
The Readout LOUD Adam Feuerstein and Meg Tirrell Listen: What’s next for Roche, a debate over second boosters, & Vertex’s recent success
The Readout LOUD Damian Garde, Meg Tirrell and Adam Feuerstein Listen: Helen Branswell on the evolving pandemic, plus the next FDA debate and the perks of being a CEO
The Readout LOUD Damian Garde, Meg Tirrell and Adam Feuerstein Listen: Doing biotech in Ukraine, drug pricing déjà vu, & Covid surges overseas
The Readout LOUD Damian Garde, Meg Tirrell and Adam Feuerstein Listen: Gilead’s growing pains, Covid’s origins, & Theranos as prestige TV
The Readout LOUD Damian Garde, Meg Tirrell and Adam Feuerstein Listen: Biden’s plans for Covid pills, the latest vaccine data, & fighting about CRISPR
The Readout LOUD Damian Garde, Meg Tirrell and Adam Feuerstein Listen: Medical racism, new Covid vaccines, & the resilience of Regeneron
The Readout LOUD Damian Garde and Meg Tirrell Jennifer Doudna and Marty Chavez on where CRISPR meets Wall Street
The Readout LOUD Damian Garde, Meg Tirrell and Adam Feuerstein Listen: Robert Califf’s FDA return, the future of CRISPR, & another vaccine delay
The Readout LOUD Damian Garde, Meg Tirrell and Adam Feuerstein Listen: Eric Lander’s resignation, FDA’s about-face, & Pfizer’s lucrative pandemic
The Readout LOUD Meg Tirrell, Adam Feuerstein and Damian Garde The quest for the small molecule holy grail with Merck’s head of R&D
The Readout LOUD Damian Garde, Meg Tirrell and Adam Feuerstein Listen: Califf’s sudden jeopardy, the quest for a PCSK9 pill, & Covid vaccines for kids
The Readout LOUD Adam Feuerstein, Damian Garde and Meg Tirrell ‘There’s no free lunch with drugs’: Janet Woodcock talks Covid monoclonal antibodies and pediatric vaccines
The Readout LOUD Damian Garde, Meg Tirrell and Adam Feuerstein Listen: Janet Woodcock on Covid antibodies, vaccines for kids, and responding to Omicron
The Readout LOUD Damian Garde, Meg Tirrell and Adam Feuerstein Listen: Biotech’s red tape, the latest billionaire science project, & a (possible) Omicron reprieve
The Readout LOUD Damian Garde, Meg Tirrell and Adam Feuerstein Listen: #JPM22 in review, Biogen’s worsening fortunes, & the future of RNA drugs
The Readout LOUD Damian Garde, Meg Tirrell and Adam Feuerstein Listen: Biotech in 2022, the Omicron surge, & the Elizabeth Holmes verdict
The Readout LOUD Damian Garde, Meg Tirrell and Adam Feuerstein Listen: Covid in 2022, J.P. Morgan bows to pressure, & the year in review
The Readout LOUD Adam Feuerstein, Meg Tirrell and Damian Garde Listen: Biogen, Biogen, Biogen, with a dash of Omicron
The Readout LOUD Damian Garde, Meg Tirrell and Adam Feuerstein Carlos del Rio on Covid antivirals, an FDA conundrum, & the rise of Omicron
The Readout LOUD Damian Garde, Meg Tirrell and Adam Feuerstein Listen: Biogen’s scientific succession & Michael Osterholm on pandemic Thanksgiving
The Readout LOUD Damian Garde, Meg Tirrell and Adam Feuerstein Listen: Moderna v. NIH, psilocybin as a medicine, & the cultural intake of pharma CEOs
The Readout LOUD Adam Feuerstein and Meg Tirrell John Maraganore on what comes next for Alnylam and his career
